Agilon Health Inc (NYSE: AGL) kicked off on Friday, down -3.46% from the previous trading day, before settling in for the closing price of $2.31. Over the past 52 weeks, AGL has traded in a range of $1.50-$7.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 3.29% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 43.88%. With a float of $303.70 million, this company’s outstanding shares have now reached $413.02 million.
In an organization with 1076 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -0.53%, operating margin of -5.11%, and the pretax margin is -4.23%.
Agilon Health Inc (AGL) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of Agilon Health Inc is 26.95%, while institutional ownership is 73.51%. The most recent insider transaction that took place on Dec 13 ’24, was worth 55,085. In this transaction Director of this company bought 25,000 shares at a rate of $2.20, taking the stock ownership to the 73,166 shares. Before that another transaction happened on Dec 11 ’24, when Company’s Director bought 25,062 for $2.01, making the entire transaction worth $50,269. This insider now owns 66,144 shares in total.
Agilon Health Inc (AGL) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.90% during the next five years compared to 3.29% growth over the previous five years of trading.
Agilon Health Inc (NYSE: AGL) Trading Performance Indicators
Take a look at Agilon Health Inc’s (AGL) current performance indicators. Last quarter, stock had a quick ratio of 1.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.62, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Agilon Health Inc (AGL)
Let’s dig in a bit further. During the last 5-days, its volume was 2.51 million. That was inferior than the volume of 5.27 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 24.46%.
During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 4.23%, which indicates a significant decrease from 38.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.13 in the past 14 days, which was lower than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.55, while its 200-day Moving Average is $3.02. However, in the short run, Agilon Health Inc’s stock first resistance to watch stands at $2.30. Second resistance stands at $2.36. The third major resistance level sits at $2.41. If the price goes on to break the first support level at $2.18, it is likely to go to the next support level at $2.14. The third support level lies at $2.07 if the price breaches the second support level.
Agilon Health Inc (NYSE: AGL) Key Stats
The company with the Market Capitalisation of 923.11 million has total of 413,952K Shares Outstanding. Its annual sales at the moment are 6,061 M in contrast with the sum of -260,150 K annual income. Company’s last quarter sales were recorded 1,533 M and last quarter income was 12,110 K.
